WHOModelListof
EssentialMedicines
19thList(April2015)
(AmendedAugust2015)
Statusofthisdocument
ThisisareprintofthetextontheWHOMedicineswebsite
http://www.who.int/medicines/publications/essentialmedicines/en/
Thepublishedmaterialisbeingdistributedwithoutwarrantofanykind,eitherexpressedorimplied.Theresponsibilityfortheinterpretationanduseofthemateriallieswiththereader.Innoeventshallthe
WorldHealthOrganizationbeliablefordamagesarisingfromitsuse.
19theditionWHOModelListofEssentialMedicines(April2015)ExplanatorynotesThecorelistpresentsalistofminimummedicineneedsforabasichealthcaresystem,listingthemostefficacious,safeandcosteffectivemedicinesforpriorityconditions.Priorityconditionsareselectedonthebasisofcurrentandestimatedfuturepublichealthrelevance,andpotentialforsafeandcosteffectivetreatment.Thecomplementarylistpresentsessentialmedicinesforprioritydiseases,forwhichspecializeddiagnosticormonitoringfacilities,and/orspecialistmedicalcare,and/orspecialisttrainingareneeded.Incaseofdoubtmedicinesmayalsobelistedascomplementaryonthebasisofconsistenthighercostsorlessattractivecosteffectivenessinavarietyofsettings.Thesquareboxsymbol()isprimarilyintendedtoindicatesimilarclinicalperformancewithinapharmacologicalclass.Thelistedmedicineshouldbetheexampleoftheclassforwhichthereisthebestevidenceforeffectivenessandsafety.Insomecases,thismaybethefirstmedicinethatislicensedformarketing;inotherinstances,subsequentlylicensedcompoundsmaybesaferormoreeffective.Wherethereisnodifferenceintermsofefficacyandsafetydata,thelistedmedicineshouldbetheonethatisgenerallyavailableatthelowestprice,basedoninternationaldrugpriceinformationsources.NotallsquareboxesareapplicabletomedicineselectionforchildrenseethesecondEMLcfordetails.TherapeuticequivalenceisindicatedonlyonthebasisofreviewsofefficacyandsafetyandwhenconsistentwithWHOclinicalguidelines.Nationallistsshouldnotuseasimilarsymbolandshouldbespecificintheirfinalselection,whichwoulddependonlocalavailabilityandprice.Theasymbolindicatesthatthereisanageorweightrestrictiononuseofthemedicine;detailsforeachmedicinecanbefoundinTable1.1.Wherethe[c]symbolisplacednexttothecomplementarylistitsignifiesthatthemedicine(s)require(s)specialistdiagnosticormonitoringfacilities,and/orspecialistmedicalcare,and/orspecialisttrainingfortheiruseinchildren.Wherethe[c]symbolisplacednexttoanindividualmedicineorstrengthofmedicineitsignifiesthatthereisaspecificindicationforrestrictingitsusetochildren.ThepresenceofanentryontheEssentialMedicinesListcarriesnoassuranceastopharmaceuticalquality.Itistheresponsibilityoftherelevantnationalorregionaldrugregulatoryauthoritytoensurethateachproductisofappropriatepharmaceuticalquality(includingstability)andthat,whenrelevant,differentproductsareinterchangeable.ForrecommendationsandadviceconcerningallaspectsofthequalityassuranceofmedicinesseetheWHOMedicineswebsitehttp://www.who.int/medicines/areas/quality_assurance.Medicinesanddosageformsarelistedinalphabeticalorderwithineachsectionandthereisnoimplicationofpreferenceforoneformoveranother.Standardtreatmentguidelinesshouldbeconsultedforinformationonappropriatedosageforms.ThemaintermsusedfordosageformsintheEssentialMedicinesListcanbefoundinTable1.2.
DefinitionsofmanyofthesetermsandpharmaceuticalqualityrequirementsapplicabletothedifferentcategoriesarepublishedinthecurrenteditionofTheInternationalPharmacopoeiahttp://www.who.int/medicines/publications/pharmacopoeia.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 1
1. ANAESTHETICS
1.1 General anaesthetics and oxygen
1.1.1 Inhalational medicines
halothane Inhalation.isoflurane Inhalation.nitrousoxide Inhalation.oxygen Inhalation (medicinalgas).1.1.2 Injectable medicinesketamine Injection:50mg(ashydrochloride)/ mL in10mLvial.
propofol*Injection:10 mg/ mL;20 mg/ mL.*Thiopentalmaybeusedasanalternativedependingonlocalavailabilityandcost.
1.2 Local anaesthetics
bupivacaineInjection: 0.25%;0.5%(hydrochloride)invial.Injectionforspinalanaesthesia:0.5%(hydrochloride)in4mLampouletobemixedwith7.5%glucosesolution.
lidocaine
Injection: 1%;2%(hydrochloride)invial.Injectionforspinalanaesthesia:5%(hydrochloride)in2mLampouletobemixedwith7.5%glucosesolution.Topicalforms:2%to4%(hydrochloride).
lidocaine+epinephrine(adrenaline)Dentalcartridge: 2%(hydrochloride)+epinephrine1:80000.Injection:1%;2%(hydrochlorideorsulfate)+epinephrine1:200000invial.
ComplementaryList
ephedrineInjection:30mg(hydrochloride)/mLin1mLampoule.(Foruseinspinalanaesthesiaduringdelivery,topreventhypotension).
1.3 Preoperative medication and sedation for short-term procedures
atropine Injection: 1mg(sulfate)in1 mL ampoule.
midazolamInjection: 1mg/ mL.Oralliquid:2mg/mL[c].Tablet:7.5mg;15mg.
morphine Injection: 10mg(sulfate orhydrochloride)in1mLampoule.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 2
2. MEDICINES FOR PAIN AND PALLIATIVE CARE
2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)
acetylsalicylicacidSuppository: 50mgto150mg.Tablet:100mgto500mg.
ibuprofenaOralliquid: 200mg/5 mL.Tablet:200mg;400mg;600mg.a Not in children less than 3 months.
paracetamol*
Oralliquid: 125mg/5 mL.Suppository:100mg.Tablet:100mgto500mg.*Notrecommendedforantiinflammatoryuseduetolackofprovenbenefittothateffect.
2.2 Opioid analgesics
codeine Tablet: 30mg(phosphate).
morphine*
Granules(slowrelease;tomixwithwater):20mg200mg(morphinesulfate).Injection:10mg(morphinehydrochlorideormorphinesulfate)in1mLampoule.Oralliquid:10mg(morphinehydrochlorideormorphinesulfate)/5mL.Tablet(slowrelease):10mg200mg(morphinehydrochlorideormorphinesulfate).Tablet(immediaterelease):10mg(morphinesulfate).*Alternativeslimitedtohydromorphoneandoxycodone
2.3 Medicines for other common symptoms in palliative care
amitriptyline Tablet:10mg;25mg;75mg.
cyclizine[c] Injection:50mg/ mL.Tablet:50mg.
dexamethasone
Injection:4mg/ mL in1 mL ampoule(asdisodiumphosphatesalt).Oralliquid:2mg/5mL.Tablet:2mg[c];4mg.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 3
diazepam
Injection:5mg/ mL.Oralliquid:2mg/5mL.Rectalsolution:2.5mg;5mg;10mg.Tablet:5mg;10mg.
docusatesodium Capsule:100mg.Oralliquid:50mg/5mL.
fluoxetinea Solidoraldosageform: 20mg(ashydrochloride).a >8 years.
haloperidolInjection: 5mgin1 mL ampoule.Oralliquid:2mg/mL.Solidoraldosageform:0.5mg;2mg;5mg.
hyoscinebutylbromide Injection:20mg/mL.
hyoscinehydrobromide[c] Injection:400micrograms/ mL;600micrograms/mL.Transdermalpatches:1mg/72hours.
lactulose[c] Oralliquid:3.13.7g/5mL.loperamide Solidoraldosageform:2mg.
metoclopramide
Injection:5mg (hydrochloride)/mLin2mLampoule.Oralliquid:5mg/5mL.Solidoralform:10mg(hydrochloride).
midazolamInjection:1 mg/ mL;5 mg/ mL.Solidoraldosageform:7.5mg;15mg.Oralliquid:2mg/mL[c].
ondansetron[c] a
Injection:2mgbase/ mL in2mLampoule(ashydrochloride).Oralliquid:4mgbase/5mL.Solidoraldosageform:Eq4mgbase;Eq8mgbase.a >1 month.
senna Oralliquid:7.5mg/5mL.3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
dexamethasone Injection:4mg/ mL in1 mL ampoule(asdisodiumphosphatesalt).
epinephrine(adrenaline) Injection: 1mg(ashydrochlorideorhydrogentartrate)in1mLampoule.
hydrocortisone Powderforinjection: 100mg(assodiumsuccinate)invial.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 4
loratadine*
Oralliquid:1mg/ mL.Tablet:10mg.*Theremaybearoleforsedatingantihistaminesforlimitedindications(EMLc).
prednisolone Oralliquid: 5 mg/ mL [c].Tablet:5mg;25mg.
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS
4.1 Non-specific
charcoal,activated Powder.4.2 Specific
acetylcysteineInjection: 200mg/ mL in10 mLampoule.Oralliquid:10%[c];20%[c].
atropine Injection: 1mg(sulfate)in1 mLampoule.calciumgluconate Injection: 100mg/ mL in10 mLampoule.methylthioniniumchloride(methyleneblue) Injection:10mg/mLin10mLampoule.
naloxone Injection: 400micrograms(hydrochloride)in1 mLampoule.
penicillamine Solidoraldosageform: 250mg.potassiumferrichexacyanoferrate(II)2H2O(Prussianblue) Powderfororaladministration.
sodiumnitrite Injection: 30mg/ mL in10 mLampoule.sodiumthiosulfate Injection: 250mg/ mL in50 mLampoule.
ComplementaryListdeferoxamine Powderforinjection: 500mg(mesilate)invial.dimercaprol Injectioninoil: 50mg/ mL in2mLampoule.
fomepizole Injection:5mg/ mL (sulfate)in20mLampouleor1 g/mL(base)in1.5mLampoule.
sodiumcalciumedetate Injection: 200mg/ mL in5 mLampoule.succimer Solidoraldosageform: 100mg.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 5
5. ANTICONVULSANTS/ANTIEPILEPTICS
carbamazepineOralliquid: 100mg/5 mL.Tablet(chewable):100mg;200mg.Tablet(scored):100mg;200mg.
diazepam Gelorrectalsolution:5 mg/ mLin0.5mL;2 mL;4mLtubes.
lorazepam Parenteralformulation:2mg/mLin1mLampoule;4mg/mLin1mLampoule.
magnesiumsulfate*
Injection: 0.5g/ mL in2 mL ampoule(equivalentto1gin2mL;50%weight/volume);0.5g/mLin10mLampoule(equivalentto5gin10mL;50%weight/volume).*Foruseineclampsiaandseverepreeclampsiaandnotforotherconvulsantdisorders.
midazolam
Solutionfororomucosaladministration:5mg/mL;10mg/mLAmpoule*:1mg/mL;10mg/mL*forbuccaladministrationwhensolutionfororomucosaladministrationisnotavailable
phenobarbitalInjection:200mg/ mL (sodium).Oralliquid:15mg/5mL.Tablet:15mgto100mg.
phenytoin
Injection: 50mg/ mL in5 mLvial(sodiumsalt).Oralliquid:25mgto30mg/5mL.*Solidoraldosageform:25mg;50mg;100mg(sodiumsalt).Tablet(chewable):50mg.*Thepresenceofboth25mg/5mLand30mg/5mLstrengthsonthesamemarketwouldcauseconfusioninprescribinganddispensingandshouldbeavoided.
valproicacid(sodiumvalproate)
Oralliquid: 200mg/5 mL.Tablet(crushable):100mg.Tablet(entericcoated):200mg;500mg(sodiumvalproate).
ComplementaryList
ethosuximideCapsule: 250mg.Oralliquid:250mg/5mL.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 6
valproicacid(sodiumvalproate) Injection:100mg/mLin4mLampoule;100mg/mLin10mLampoule.
6. ANTI-INFECTIVE MEDICINES
6.1 Anthelminthics
6.1.1 Intestinal anthelminthics
albendazole Tablet(chewable): 400mg.levamisole Tablet: 50mg;150mg(ashydrochloride).mebendazole Tablet(chewable): 100mg;500mg.niclosamide Tablet(chewable): 500mg.praziquantel Tablet: 150mg;600mg.
pyrantelOralliquid: 50mg(asembonateorpamoate)/ mL.Tablet(chewable):250mg(asembonateorpamoate).
6.1.2 Antifilarials
albendazole Tablet(chewable): 400mg.diethylcarbamazine Tablet: 50mg;100mg(dihydrogencitrate).ivermectin Tablet(scored): 3mg.6.1.3 Antischistosomals and other antitrematode medicines
praziquantel Tablet: 600mg.triclabendazole Tablet: 250mg.
ComplementaryList
oxamniquine*
Capsule: 250mg.Oralliquid:250mg/5mL.*Oxamniquineislistedforusewhenpraziquanteltreatmentfails.
6.2 Antibacterials
6.2.1 Beta-lactam medicines
amoxicillinPowderfororalliquid: 125mg(astrihydrate)/5mL;250mg(astrihydrate)/5mL[c].Solidoraldosageform:250mg;500mg(astrihydrate).
amoxicillin+clavulanicacid
Oralliquid: 125 mgamoxicillin+31.25mgclavulanicacid/5mLAND250mgamoxicillin+62.5mgclavulanicacid/5mL[c].Tablet:500mg(astrihydrate)+125mg(aspotassiumsalt).
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 7
ampicillin Powderforinjection: 500mg;1g(assodiumsalt)invial.
benzathinebenzylpenicillinPowderforinjection: 900 mgbenzylpenicillin(=1.2millionIU)in5mLvial[c];1.44gbenzylpenicillin(=2.4millionIU)in5mLvial.
benzylpenicillin Powderforinjection: 600mg(=1millionIU);3g(=5millionIU)(sodiumorpotassiumsalt)invial.
cefalexin[c] Powderforreconstitutionwithwater:125mg/5mL;250mg/5mL(anhydrous).Solidoraldosageform:250mg(asmonohydrate).
cefazolin*aPowderforinjection:1g(assodiumsalt)invial.*Forsurgicalprophylaxis.a >1 month.
cefixime*Capsule: 400mg(astrihydrate).*Listedonlyforsingledosetreatmentofuncomplicatedanogenitalgonorrhoea.
ceftriaxone*a
Powderforinjection: 250mg;1g(assodiumsalt)invial.*Donotadministerwithcalciumandavoidininfantswithhyperbilirubinaemia.a >41 weeks corrected gestational age.
cloxacillin
Capsule: 500mg;1g(assodiumsalt).Powderforinjection:500mg(assodiumsalt)invial.Powderfororalliquid:125mg(assodiumsalt)/5mL.
phenoxymethylpenicillinPowderfororalliquid: 250mg(aspotassiumsalt)/5mL.Tablet:250mg(aspotassiumsalt).
procainebenzylpenicillin*
Powderforinjection: 1g(=1millionIU);3g(=3millionIU)invial.*Procainebenzylpenicillinisnotrecommendedasfirstlinetreatmentforneonatalsepsisexceptinsettingswithhighneonatalmortality,whengivenbytrainedhealthworkersincaseswherehospitalcareisnotachievable.
ComplementaryList
cefotaxime*[c]Powderforinjection:250mgpervial(assodiumsalt).*3rdgenerationcephalosporinofchoiceforuseinhospitalizedneonates.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 8
ceftazidime Powderforinjection:250mgor1g(aspentahydrate)invial.
imipenem*+cilastatin*
Powderforinjection: 250mg(asmonohydrate)+250mg(assodiumsalt);500mg(asmonohydrate)+500mg(assodiumsalt)invial.*Listedonlyforthetreatmentoflifethreateninghospitalbasedinfectionduetosuspectedorprovenmultidrugresistantinfection.Meropenemisindicatedforthetreatmentofmeningitisandislicensedforuseinchildrenovertheageof3months.
6.2.2 Other antibacterials
azithromycin*
Capsule: 250mg;500mg(anhydrous).Oralliquid:200mg/5mL.*OnlylistedforsingledosetreatmentofgenitalChlamydiatrachomatisandoftrachoma.
chloramphenicol
Capsule: 250mg.Oilysuspensionforinjection*:0.5g(assodiumsuccinate)/mLin2mLampoule.*Onlyforthepresumptivetreatmentofepidemicmeningitisinchildrenolderthan2years.Oralliquid:150mg(aspalmitate)/5mL.Powderforinjection:1g(sodiumsuccinate)invial.
ciprofloxacin*
Oralliquid: 250mg/5 mL (anhydrous)[c].SolutionforIVinfusion:2mg/mL(ashyclate)[c].Tablet:250mg(ashydrochloride).*Squareboxappliestoadultsonly.
clarithromycin*Solidoraldosageform: 500mg.*ForuseincombinationregimensforeradicationofH.Pyloriinadults.
doxycyclinea
Oralliquid:25 mg/5 mL [c];50mg/5mL(anhydrous)[c].Solidoraldosageform:50mg[c];100mg(ashyclate).aUse in children
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 9
erythromycin
Powderforinjection: 500mg(aslactobionate)invial.Powderfororalliquid:125mg/5mL(asstearateorestolateorethylsuccinate).Solidoraldosageform:250mg(asstearateorestolateorethylsuccinate).
gentamicin Injection: 10mg;40mg(assulfate)/mLin2 mLvial.
metronidazole
Injection: 500mgin100 mL vial.Oralliquid:200mg(asbenzoate)/5mL.Suppository:500mg;1g.Tablet:200mgto500mg.
nitrofurantoin Oralliquid: 25 mg/5 mL [c].Tablet:100mg.
spectinomycin Powderforinjection: 2g(ashydrochloride)invial.
sulfamethoxazole+trimethoprim
Injection:
80mg+16mg/mLin5mLampoule;80mg+16mg/mLin10mLampoule.Oralliquid:200mg+40mg/5mL.Tablet:100mg+20mg;400mg+80mg;800mg+160mg.
trimethoprima Oralliquid: 50mg/5 mL [c].Tablet:100mg;200mg.a >6 months.
ComplementaryList
clindamycinCapsule:150mg(ashydrochloride).Injection:150mg(asphosphate)/mL.Oralliquid:75mg/5mL(aspalmitate)[c].
vancomycin Powderforinjection: 250mg(ashydrochloride)invial.6.2.3 Antileprosy medicinesMedicinesused in the treatmentof leprosy shouldneverbeused except in combination.Combinationtherapyisessentialtopreventtheemergenceofdrugresistance.Colourcodedblisterpacks(MDTblisterpacks) containing standard twomedicine (paucibacillary leprosy) or threemedicine (multibacillaryleprosy)combinationsforadultandchildhoodleprosyshouldbeused.MDTblisterpackscanbesuppliedfreeofchargethroughWHO.clofazimine Capsule: 50mg;100mg.dapsone Tablet: 25mg;50mg;100mg.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 10
rifampicin Solidoraldosageform: 150mg;300mg.6.2.4 Antituberculosis medicines
WHOrecommendsandendorsestheuseoffixeddosecombinationsandthedevelopmentofappropriatenewfixeddosecombinations,includingmodifieddosageforms,nonrefrigeratedproductsandpaediatricdosageformsofassuredpharmaceuticalquality.
ethambutol Oralliquid: 25 mg/ mL [c].Tablet:100mgto400mg(hydrochloride).
ethambutol+isoniazid Tablet: 400mg+150mg.ethambutol+isoniazid+pyrazinamide+rifampicin Tablet:275mg+75mg+400mg+150mg.
ethambutol+isoniazid+rifampicin Tablet:275mg+75mg+150mg.
isoniazidOralliquid: 50 mg/5 mL [c].Tablet:100mgto300mg.Tablet(scored):50mg.
isoniazid+pyrazinamide+rifampicinTablet:
75mg+400mg+150mg.150mg+500mg+150mg(Forintermittentusethreetimesweekly).
isoniazid+rifampicin
Tablet:
75mg+150mg;150mg+300mg.60mg+60mg(Forintermittentusethreetimesweekly).150mg+150mg(Forintermittentusethreetimesweekly).
pyrazinamide
Oralliquid: 30 mg/ mL [c].Tablet:400mg.Tablet(dispersible):150mg.Tablet(scored):150mg.
rifabutinCapsule: 150mg.**ForuseonlyinpatientswithHIVreceivingproteaseinhibitors.
rifampicin Oralliquid: 20 mg/ mL [c].Solidoraldosageform:150mg;300mg.
rifapentine*Tablet:150mg*FortreatmentoflatentTBinfection(LTBI)only
streptomycin Powderforinjection: 1g(assulfate)invial.ComplementaryList
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 11
Reservesecondlinedrugsforthetreatmentofmultidrugresistanttuberculosis(MDRTB)shouldbeusedinspecializedcentresadheringtoWHOstandardsforTBcontrol.
amikacin Powderforinjection:100mg;500mg;1g(assulfate)invial.
bedaquiline Tablet:100mgcapreomycin Powderforinjection: 1g(assulfate)invial.
cycloserine*Solidoraldosageform: 250mg.*Terizidonemaybeanalternative
delamanid Tablet:50mg
ethionamide*Tablet:125mg;250mg.*Protionamidemaybeanalternative.
kanamycin Powderforinjection:1g(assulfate)invial.
levofloxacin*Tablet:250mg;500mg;750mg.*Ofloxacinandmoxifloxacinmaybealternativesbasedonavailabilityandprogrammeconsiderations.
linezolid
Injectionforintravenousadministration:2mg/mLin300mLbagPowderfororalliquid:100mg/5mL,Tablet:400mg;600mg
paminosalicylicacidGranules: 4ginsachet.Tablet:500mg.
streptomycin[c] Powderforinjection:1g(assulfate)invial.6.3 Antifungal medicines
amphotericinB Powderforinjection: 50mginvial(assodiumdeoxycholateorliposomalcomplex).
clotrimazoleVaginalcream: 1%;10%.Vaginaltablet:100mg;500mg.
fluconazoleCapsule: 50mg.Injection:2mg/mLinvial.Oralliquid:50mg/5mL.
flucytosineCapsule: 250mg.Infusion:2.5gin250mL.
griseofulvinOralliquid:125mg/5 mL [c].Solidoraldosageform:125mg;250mg.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 12
nystatin
Lozenge: 100000IU.Oralliquid:50mg/5mL[c];100000IU/mL[c].Pessary:100000IU.Tablet:100000IU;500000IU.
ComplementaryListpotassiumiodide Saturatedsolution.
6.4 Antiviral medicines
6.4.1 Antiherpes medicines
aciclovir
Oralliquid: 200mg/5 mL [c].Powderforinjection:250mg(assodiumsalt)invial.Tablet:200mg.
6.4.2 Antiretrovirals
Based on current evidence and experience of use, medicines in the following three classes ofantiretrovirals are included as essentialmedicines for treatment andpreventionofHIV (preventionofmothertochildtransmissionandpostexposureprophylaxis).WHOemphasizestheimportanceofusingtheseproductsinaccordancewithglobalandnationalguidelines. WHOrecommendsandendorsestheuse of fixeddose combinations and the development of appropriate new fixeddose combinations,including modified dosage forms, nonrefrigerated products and paediatric dosage forms of assuredpharmaceuticalquality.Scored tablets can be used in children and therefore can be considered for inclusion in the listing oftablets,providedthatadequatequalityproductsareavailable.6.4.2.1 Nucleoside/Nucleotide reverse transcriptase inhibitors
abacavir(ABC)Oralliquid: 100mg(assulfate)/5mL.Tablet:300mg(assulfate).
lamivudine(3TC)Oralliquid: 50mg/5 mL.Tablet:150mg.
stavudine(d4T)Capsule: 15 mg;20mg;30mg.Powderfororalliquid:5mg/5mL.
tenofovirdisoproxilfumarate(TDF) Tablet:300mg(tenofovirdisoproxilfumarateequivalentto245mgtenofovirdisoproxil).
zidovudine(ZDVorAZT)
Capsule: 100mg;250mg.Oralliquid:50mg/5mL.SolutionforIVinfusioninjection:10mg/mLin20mLvial.Tablet:300mg.
6.4.2.2 Non-nucleoside reverse transcriptase inhibitors
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 13
efavirenz(EFVorEFZ)a Capsule: 50mg;100mg;200mg.Tablet:200mg(scored);600mg.a >3 years or >10 kg weight.
nevirapine(NVP)Oralliquid: 50mg/5 mL.Tablet:50mg(dispersible);200mg.
6.4.2.3 Protease inhibitorsSelectionofprotease inhibitor(s) from theModelListwillneed tobedeterminedbyeachcountryafterconsideration of international and national treatment guidelines and experience. Ritonavir isrecommendedforuseincombinationasapharmacologicalbooster,andnotasanantiretroviralinitsownright.Allotherproteaseinhibitorsshouldbeusedinboostedforms(e.g.withritonavir).
atazanaviraSolidoraldosageform:100mg;150mg;300mg(assulfate).a >25 kg.
darunavir aTablet:75mg;400mg;600mg;800mga >3 years
lopinavir+ritonavir(LPV/r)Oralliquid: 400mg+100mg/5mL.Tablet(heatstable):100mg+25mg;200mg+50mg.
ritonavirOralliquid: 400mg/5 mL.Tablet(heatstable):25mg;100mg.
saquinavir(SQV)a Solidoraldosageform: 200mg;500mg(asmesilate).a >25 kg.
FIXED-DOSE COMBINATIONS
abacavir+lamivudine Tablet(dispersible,scored):60mg(assulfate)+30mg
efavirenz+emtricitabine*+tenofovir
Tablet:600mg+200mg+300mg(disoproxilfumarateequivalentto245mgtenofovirdisoproxil).*Emtricitabine(FTC)isanacceptablealternativeto3TC,basedonknowledgeofthepharmacology,theresistancepatternsandclinicaltrialsofantiretrovirals.
emtricitabine*+tenofovir
Tablet: 200mg+300mg(disoproxilfumarateequivalentto245mgtenofovirdisoproxil).*Emtricitabine(FTC)isanacceptablealternativeto3TC,basedonknowledgeofthepharmacology,theresistancepatternsandclinicaltrialsofantiretrovirals.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 14
lamivudine+nevirapine+stavudineTablet: 150mg+200mg+30mg.Tablet(dispersible):30mg+50mg+6mg[c].
lamivudine+nevirapine+zidovudine Tablet: 30mg+50mg+60mg[c];150mg+200 mg+300mg.
lamivudine+zidovudine Tablet: 30mg+60mg[c];150mg+300mg.6.4.3 Other antivirals
oseltamivir*
Capsule:30mg;45mg;75mg(asphosphate).Oralpowder:12mg/mL.*potentiallysevereorcomplicatedillnessduetoconfirmedorsuspectedinfluenzavirusinfectioninaccordancewithWHOtreatmentguidelines.
ribavirin*
Injectionforintravenousadministration:800mgand1gin10mLphosphatebuffersolution.Solidoraldosageform:200mg;400mg;600mg.*Forthetreatmentofviralhaemorrhagicfevers
valganciclovir*
Tablet:450mg.*Forthetreatmentofcytomegalovirusretinitis(CMVr).
6.4.4 Antihepatitis medicines6.4.4.1 Medicines for hepatitis B
6.4.4.1.1 Nucleoside/Nucleotide reverse transcriptase inhibitors
entecavirOralliquid:0.05mg/mLTablet:0.5mg;1mg
tenofovirdisoproxilfumarate(TDF) Tablet:300mg(tenofovirdisoproxilfumarateequivalentto245mgtenofovirdisoproxil).6.4.4.2 Medicines for hepatitis C
Basedoncurrentevidence,medicinesinthefollowingclassesofdirectactingantiviralmedicinesareincludedasessentialmedicinesfortreatmentofhepatitisCvirusinfection.WHOguidelinesrecommendspecificcombinationtherapyutilizingmedicinesfromdifferentclasses. 6.4.4.2.1 Nucleotide polymerase inhibitors
sofosbuvir Tablet:400mg6.4.4.2.2 Protease inhibitors
simeprevir Capsule150mg6.4.4.2.3 NS5A inhibitors
daclatasvir Tablet:30mg;60mg (ashydrochloride)6.4.4.2.4 Non-nucleoside polymerase inhibitors
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 15
dasabuvir Tablet: 250mg6.4.4.2.5 Other antivirals
ribavirin*
Injectionforintravenousadministration:800mgand1gin10mLphosphatebuffersolution.Solidoraldosageform:200mg;400mg;600mg.*ForthetreatmentofhepatitisC,incombinationwithpeginterferonand/ordirectactingantiviralmedicines
ComplementaryList
pegylatedinterferonalfa(2aor2b)*
Vialorprefilledsyringe:180micrograms(peginterferonalfa2a),80microgram,100microgram(peginterferonalfa2b).*Tobeusedincombinationwithribavirin.
FIXED-DOSE COMBINATIONS
Alternative combinations of DAAs from different pharmacological classes are possible
ledipasvir+sofosbuvir Tablet:90mg+400mg.ombitasvir+paritaprevir+ritonavir Tablet:12.5mg+75mg+50mg6.5 Antiprotozoal medicines6.5.1 Antiamoebic and antigiardiasis medicines
diloxanidea Tablet: 500mg(furoate).a >25 kg.
metronidazoleInjection: 500mgin100 mL vial.Oralliquid:200mg(asbenzoate)/5mL.Tablet:200mgto500mg.
6.5.2 Antileishmaniasis medicines
amphotericinB Powderforinjection: 50mginvial(assodiumdeoxycholateorliposomalcomplex).
miltefosine Solidoraldosageform:10mg;50mg.paromomycin Solutionforintramuscularinjection:750mgof
paromomycinbase(asthesulfate).
sodiumstibogluconateormeglumineantimoniateInjection: 100mg/ mL,1vial=30mLor30%,equivalenttoapproximately8.1%antimony(pentavalent)in5mLampoule.
6.5.3 Antimalarial medicines
6.5.3.1 For curative treatment
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 16
Medicines for the treatment of P. falciparummalaria cases should be used in combination. The listcurrentlyrecommendscombinationsaccordingto treatmentguidelines. WHOrecognizesthatnotallofthe fixed dose combinations (FDCs) in the WHO treatment guidelines exist, and encourages theirdevelopment and rigorous testing. WHO also encourages development and testing of rectal dosageformulations.
amodiaquine*Tablet: 153mg or200mg(ashydrochloride).*Tobeusedincombinationwithartesunate50mg.
artemether*Oilyinjection: 80mg/ mL in1mLampoule.*Foruseinthemanagementofseveremalaria.
artemether+lumefantrine*
Tablet: 20mg+120mg.Tablet(dispersible):20mg+120mg[c].*Notrecommendedinthefirsttrimesterofpregnancyorinchildrenbelow5kg.
artesunate*
Injection: ampoules,containing60mganhydrousartesunicacidwithaseparateampouleof5%sodiumbicarbonatesolution.Foruseinthemanagementofseveremalaria.Rectaldosageform:50mg[c];200mgcapsules(forprereferraltreatmentofseveremalariaonly;patientsshouldbetakentoanappropriatehealthfacilityforfollowupcare)[c].Tablet:50mg.*Tobeusedincombinationwitheitheramodiaquine,mefloquineorsulfadoxine+pyrimethamine.
artesunate+amodiaquine*
Tablet: 25 mg+ 67.5 mg;50 mg+135mg;100 mg+270mg.*Othercombinationsthatdeliverthetargetdosesrequiredsuchas153mgor200mg(ashydrochloride)with50mgartesunatecanbealternatives.
artesunate+mefloquine Tablet: 25 mg+ 55mg;100 mg+220mg.
chloroquine*Oralliquid: 50mg(asphosphateorsulfate)/5 mL.Tablet:100mg;150mg(asphosphateorsulfate).*ForuseonlyforthetreatmentofP.vivaxinfection.
doxycycline*Capsule: 100mg(ashydrochlorideorhyclate).Tablet(dispersible):100mg(asmonohydrate).*Foruseonlyincombinationwithquinine.
mefloquine*Tablet: 250mg(ashydrochloride).*Tobeusedincombinationwithartesunate50mg.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 17
primaquine*Tablet: 7.5mg;15mg(asdiphosphate).*OnlyforusetoachieveradicalcureofP.vivaxandP.ovaleinfections,givenfor14days.
quinine*
Injection: 300mgquininehydrochloride/mL in2mLampoule.Tablet:300mg(quininesulfate)or300mg(quininebisulfate).*Foruseonlyinthemanagementofseveremalaria,andshouldbeusedincombinationwithdoxycycline.
sulfadoxine+pyrimethamine*Tablet: 500mg+25mg.*Onlyincombinationwithartesunate50mg.
6.5.3.2 For prophylaxis
chloroquine*
Oralliquid: 50mg(asphosphateorsulfate)/5 mL.Tablet:150mg(asphosphateorsulfate).*ForuseonlyincentralAmericanregions,forP.vivaxinfections.
doxycyclinea Solidoraldosageform: 100mg(ashydrochloride orhyclate).a >8 years.
mefloquinea Tablet: 250mg(ashydrochloride).a >5 kg or >3 months.
proguanil*Tablet: 100mg(ashydrochloride).*Foruseonlyincombinationwithchloroquine.
6.5.4 Antipneumocystosis and antitoxoplasmosis medicines
pyrimethamine Tablet: 25mg.sulfadiazine Tablet:500mg.
sulfamethoxazole+trimethoprim
Injection:80mg+16mg/mLin5mLampoule;80mg+16mg/mLin10mLampoule.Oralliquid:200mg+40mg/5mL[c].Tablet:100mg+20mg;400mg+80mg[c].
ComplementaryList pentamidine Tablet: 200mg;300mg(asisethionate).
6.5.5 Antitrypanosomal medicines
6.5.5.1 African trypanosomiasis
Medicinesforthetreatmentof1ststageAfricantrypanosomiasis
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 18
pentamidine*Powderforinjection:200mg(asisetionate)invial.*TobeusedforthetreatmentofTrypanosomabruceigambienseinfection.
suraminsodium*Powderforinjection: 1ginvial.*TobeusedforthetreatmentoftheinitialphaseofTrypanosomabruceirhodesienseinfection.
Medicinesforthetreatmentof2ndstageAfricantrypanosomiasis
eflornithine*Injection:200mg(hydrochloride)/mLin100 mLbottle.*TobeusedforthetreatmentofTrypanosomabruceigambienseinfection.
melarsoprolInjection: 3.6%solution,5 mLampoule(180mgofactivecompound).
nifurtimox*
Tablet: 120mg.*Onlytobeusedincombinationwitheflornithine,forthetreatmentofTrypanosomabruceigambienseinfection.
ComplementaryList[c]melarsoprol Injection:3.6%solutionin5mLampoule(180mgof
activecompound).6.5.5.2 American trypanosomiasis
benznidazoleTablet: 12.5mg[c];100mg.Tablet(scored):50mg.
nifurtimox Tablet: 30mg;120mg;250mg.7. ANTIMIGRAINE MEDICINES7.1 For treatment of acute attack
acetylsalicylicacid Tablet: 300mgto500mg.ibuprofen[c] Tablet:200mg;400mg.
paracetamol Oralliquid: 125mg/5 mL [c].Tablet:300mgto500mg.
7.2 For prophylaxis
propranolol Tablet: 20mg;40mg(hydrochloride).8. ANTINEOPLASTICS AND IMMUNOSUPPRESSIVES
Medicineslistedbelowshouldbeusedaccordingtoprotocolsfortreatmentofthediseases. 8.1 Immunosuppressive medicines
ComplementaryList
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 19
azathioprine Powderforinjection:100mg(assodiumsalt)invial.Tablet(scored):50mg.
ciclosporin
Capsule: 25mg.Concentrateforinjection:50mg/mLin1mLampoulefororgantransplantation.
8.2 Cytotoxic and adjuvant medicines
ComplementaryList
alltransretinoidacid(ATRA) Capsule:10mg. Acutepromyelocyticleukaemia.allopurinol[c] Tablet:100mg;300mg.
asparaginasePowderforinjection:10000IUinvial.
Acutelymphoblasticleukaemia.
bendamustineInjection: 45mg/0.5mL;180mg/2mL.
Chroniclymphocyticleukaemia Follicularlymphoma
bleomycin
Powderforinjection:15mg(assulfate)invial. Hodgkinlymphoma Kaposisarcoma Ovariangermcelltumour Testiculargermcelltumour
calciumfolinate
Injection:3mg/mLin10mLampoule.Tablet:15mg.
Earlystagecoloncancer Earlystagerectalcancer Gestationaltrophoblasticneoplasia Metastaticcolorectalcancer Osteosarcoma Burkittlymphoma
capecitabine
Tablet:150mg;500mg. Earlystagecoloncancer Earlystagerectalcancer Metastaticbreastcancer Metastaticcolorectalcancer
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 20
carboplatin
Injection:50mg/5mL;150mg/15mL;450mg/45mL;600mg/60mL.
Earlystagebreastcancer Epithelialovariancancer Nasopharyngealcancer Nonsmallcelllungcancer Osteosarcoma Retinoblastoma
chlorambucilTablet: 2mg.
Chroniclymphocyticleukaemia.
cisplatin
Injection:50mg/50mL;100mg/100mL. Cervicalcancer(asaradiosensitizer) Headandneckcancer(asaradiosensitizer) Nasopharyngealcancer(asaradiosensitizer) Nonsmallcelllungcancer Osteosarcoma Ovariangermcelltumour Testiculargermcelltumour
cyclophosphamide
Powderforinjection:500mginvial.Tablet:25mg.
Chroniclymphocyticleukaemia DiffuselargeBcelllymphoma Earlystagebreastcancer Gestationaltrophoblasticneoplasia Hodgkinlymphoma Follicularlymphoma Rhabdomyosarcoma Ewingsarcoma Acutelymphoblasticleukaemia Burkittlymphoma Metastaticbreastcancer.
cytarabine
Powderforinjection:100mginvial. Acutemyelogenousleukaemia Acutelymphoblasticleukaemia Acutepromyelocyticleukaemia Burkittlymphoma.
dacarbazinePowderforinjection:100mginvial.
Hodgkinlymphoma
dactinomycin
Powderforinjection: 500microgramsinvial. Gestationaltrophoblasticneoplasia Rhabdomyosarcoma Wilmstumour
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 21
daunorubicin
Powderforinjection:50mg(hydrochloride)invial. Acutelymphoblasticleukaemia Acutemyelogenousleukaemia Acutepromyelocyticleukaemia
docetaxelInjection:20mg/ mL;40mg/ mL.
Earlystagebreastcancer Metastaticbreastcancer Metastaticprostatecancer
doxorubicin
Powderforinjection: 10mg;50mg(hydrochloride)invial.
DiffuselargeBcelllymphoma Earlystagebreastcancer Hodgkinlymphoma Kaposisarcoma Follicularlymphoma Metastaticbreastcancer Osteosarcoma Ewingsarcoma Acutelymphoblasticleukaemia Wilmstumour Burkittlymphoma
etoposide
Capsule:100mg.Injection:20mg/mLin5mLampoule.
Testiculargermcelltumour Gestationaltrophoblasticneoplasia Hodgkinlymphoma Nonsmallcelllungcancer Ovariangermcelltumour Retinoblastoma Ewingsarcoma Acutelymphoblasticleukaemia Burkittlymphoma
fludarabinePowderforinjection:50mg(phosphate)invial.Tablet:10mg
Chroniclymphocyticleukaemia.
fluorouracil
Injection:50mg/mLin5mLampoule. Earlystagebreastcancer Earlystagecoloncancer Earlystagerectalcancer Metastaticcolorectalcancer Nasopharyngealcancer.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 22
filgrastim
Injection:120micrograms/0.2mL;300micrograms/0.5mL;480micrograms/0.8mLinprefilledsyringe300micrograms/mLin1mLvial,480mg/1.6mLin1.6mLvial.
Primaryprophylaxisinpatientsathighriskfordevelopingfebrileneutropeniaassociatedwithmyelotoxicchemotherapy.
Secondaryprophylaxisforpatientswhohaveexperiencedneutropeniafollowingpriormyelotoxicchemotherapy
Tofacilitateadministrationofdosedensechemotherapyregimens
gemcitabinePowderforinjection:200mginvial,1ginvial.
Epithelialovariancancer Nonsmallcelllungcancer
hydroxycarbamideSolidoraldosageform:200mg;250mg;300mg;400mg;500mg;1g.
Chronicmyeloidleukaemia.
ifosfamide
Powderforinjection: 500mgvial;1gvial;2gvial. Testiculargermcelltumour Ovariangermcelltumour Osteosarcoma Rhabdomyosarcoma Ewingsarcoma
imatinibTablet:100mg;400mg.
Chronicmyeloidleukaemia Gastrointestinalstromaltumour
irinotecanInjection: 40mg/2mLin2 mLvial;100mg/5mLin5mLvial;500mg/25mLin25mLvial.
Metastaticcolorectalcancer.
mercaptopurineTablet:50mg.
Acutelymphoblasticleukaemia Acutepromyelocyticleukaemia.
mesna
Injection:100mg/mLin4mLand10mLampoules.Tablet:400mg;600mg.
Testiculargermcelltumour Ovariangermcelltumour Osteosarcoma Rhabdomyosarcoma Ewingsarcoma.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 23
methotrexate
Powderforinjection:50mg(assodiumsalt)invial.Tablet:2.5mg(assodiumsalt).
Earlystagebreastcancer Gestationaltrophoblasticneoplasia Osteosarcoma Acutelymphoblasticleukaemia Acutepromyelocyticleukaemia
oxaliplatin
Injection:50mg/10mLin10mLvial;100mg/20mLin20mLvial;200mg/40mLin40mLvial.Powderforinjection:50mg,100mginvial.
Earlystagecoloncancer Metastaticcolorectalcancer
paclitaxel
Powderforinjection: 6mg/ mL. Epithelialovariancancer Earlystagebreastcancer Metastaticbreastcancer Kaposisarcoma Nasopharyngealcancer Nonsmallcelllungcancer Ovariangermcelltumour
procarbazine Capsule: 50mg(ashydrochloride).
rituximab
Injection: 100mg/10mLin10mLvial;500mg/50mLin50mLvial.
DiffuselargeBcelllymphoma Chroniclymphocyticleukaemia Follicularlymphoma.
tioguanine[c] Solidoraldosageform:40mg. Acutelymphoblasticleukaemia.
trastuzumabPowderforinjection:60mg;150mg;440mginvial
EarlystageHER2positivebreastcancer MetastaticHER2positivebreastcancer.
vinblastine
Powderforinjection:10mg(sulfate)invial. Hodgkinlymphoma Kaposisarcoma. Testiculargermcelltumour Ovariangermcelltumour
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 24
vincristine
Powderforinjection:1mg;5mg(sulfate)invial. DiffuselargeBcelllymphoma Gestationaltrophoblasticneoplasia Hodgkinlymphoma Kaposisarcoma Follicularlymphoma Retinoblastoma Rhabdomyosarcoma Ewingsarcoma Acutelymphoblasticleukaemia Wilmstumour Burkittlymphoma.
vinorelbineInjection: 10mg/mLin1 mLvial;50mg/5mLin5mLvial.
Nonsmallcelllungcancer Metastaticbreastcancer
8.3 Hormones and antihormones
ComplementaryList
anastrozoleTablet:1mg.
Earlystagebreastcancer Metastaticbreastcancer.
bicalutamideTablet:50mg.
Metastaticprostatecancer.
dexamethasone
Injection:4mg/ mL in1 mL ampoule(asdisodiumphosphatesalt).Oralliquid:2mg/5mL[c].
Acutelymphoblasticleukaemia.
leuprorelinDoseform
Earlystagebreastcancer Metastaticprostatecancer
hydrocortisonePowderforinjection:100mg(assodiumsuccinate)invial.
Acutelymphoblasticleukaemia.
methylprednisolone[c]
Injection: 40mg/ mL (assodiumsuccinate)in1 mLsingledosevialand5mLmultidosevials;80mg/mL(assodiumsuccinate)in1mLsingledosevial.
Acutelymphoblasticleukamia.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 25
prednisolone
Oralliquid:5mg/mL[c].Tablet:5mg;25mg.
Chroniclymphocyticleukaemia DiffuselargeBcelllymphoma Hodgkinlymphoma Follicularlymphoma Acutelymphoblasticleukaemia Burkittlymphoma
tamoxifenTablet: 10mg;20mg(ascitrate).
Earlystagebreastcancer Metastaticbreastcancer
9. ANTIPARKINSONISM MEDICINES
biperidenInjection: 5mg(lactate)in1 mLampoule.Tablet:2mg(hydrochloride).
levodopa+carbidopa Tablet: 100mg+10mg;100mg+25mg;250mg+25mg10. MEDICINES AFFECTING THE BLOOD
10.1 Antianaemia medicines
ferroussaltOralliquid: equivalentto25mgiron(assulfate)/mL.Tablet:equivalentto60mgiron.
ferroussalt+folicacidTablet: equivalentto60mgiron+400microgramsfolicacid(nutritionalsupplementforuseduringpregnancy).
folicacidTablet: 400micrograms*;1mg;5mg.*periconceptualuseforpreventionoffirstoccurrenceofneuraltubedefects
hydroxocobalamin Injection: 1mg(asacetate,ashydrochlorideorassulfate)in1mLampoule.10.2 Medicines affecting coagulation
enoxaparin*
Injection:ampouleorprefilledsyringe20mg/0.2mL;40mg/0.4mL;60mg/0.6mL;80mg/0.8mL;100mg/1mL;120mg/0.8mL;150mg/1mL*Alternativesarelimitedtonadroparinanddalteparin
heparinsodium Injection: 1000IU/ mL;5000IU/mL;20000IU/ mLin1mLampoule.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 26
phytomenadioneInjection: 1mg/ mL [c]; 10mg/mLin5mLampoule.Tablet:10mg.
protaminesulfate Injection: 10mg/ mL in5 mLampoule.tranexamicacid Injection: 100 mg/ mL in10 mLampoule.warfarin Tablet: 1mg;2mg;5mg(sodiumsalt).
ComplementaryList[c]
desmopressinInjection:4micrograms/mL(asacetate)in1mLampoule.Nasalspray:10micrograms(asacetate)perdose
heparinsodium Injection:1000IU/mL;5000IU/mLin1mLampoule.protaminesulfate Injection:10mg/mLin5mLampoule.warfarin Tablet:0.5mg;1mg;2mg;5mg(sodiumsalt).
10.3 Other medicines for haemoglobinopathies
ComplementaryList
deferoxamine*Powderforinjection: 500mg(mesilate)invial.*Deferasiroxoralformmaybeanalternative,dependingoncostandavailability.
hydroxycarbamide Solidoraldosageform:200mg;500mg;1g.11. BLOOD PRODUCTS OF HUMAN ORIGIN AND PLASMA SUBSTITUTES11.1 Blood and blood components
InaccordancewiththeWorldHealthAssemblyresolutionWHA63.12,WHOrecognizesthatachievingselfsufficiency,unlessspecialcircumstancesprecludeit,inthesupplyofsafebloodcomponentsbasedonvoluntary,nonremuneratedblooddonation,andthesecurityofthatsupplyareimportantnationalgoalstopreventbloodshortagesandmeetthetransfusionrequirementsofthepatientpopulation.AllpreparationsshouldcomplywiththeWHOrequirements.freshfrozenplasma platelets redbloodcells wholeblood 11.2 Plasma-derived medicinesAllhumanplasmaderivedmedicinesshouldcomplywiththeWHOrequirements.11.2.1 Human immunoglobulins
antiDimmunoglobulin Injection: 250microgramsinsingledosevial.Antirabiesimmunoglobulin Injection: 150IU/mLinvial.Antitetanusimmunoglobulin Injection: 500IUinvial.
ComplementaryList
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 27
normalimmunoglobulin
Intramuscularadministration:16%proteinsolution.*Intravenousadministration:5%;10%proteinsolution.**Subcutaneousadministration:15%;16%proteinsolution.**Indicatedforprimaryimmunedeficiency.**IndicatedforprimaryimmunedeficiencyandKawasakidisease.
11.2.2 Blood coagulation factors
ComplementaryListcoagulationfactorVIII Powderforinjection:500IU/vial.coagulationfactorIX Powderforinjection:500IU/vial,1000IU/vial.
11.3 Plasma substitutes
dextran70*Injectablesolution:6%.*Polygeline,injectablesolution,3.5%isconsideredasequivalent.
12. CARDIOVASCULAR MEDICINES
12.1 Antianginal medicines
bisoprolol*Tablet: 1.25 mg;5mg.*includesmetoprololandcarvedilolasalternatives.
glyceryltrinitrate Tablet(sublingual): 500micrograms.isosorbidedinitrate Tablet(sublingual): 5mg.verapamil Tablet:40mg; 80mg(hydrochloride).12.2 Antiarrhythmic medicines
bisoprolol*Tablet: 1.25 mg;5mg.*includesmetoprololandcarvedilolasalternatives.
digoxinInjection: 250micrograms/ mLin2mLampoule.Oralliquid:50micrograms/mL.Tablet:62.5micrograms;250micrograms.
epinephrine(adrenaline) Injection:100micrograms/ mL(asacidtartrate orhydrochloride)in10mLampoule.
lidocaine Injection: 20mg(hydrochloride)/mLin5mLampoule.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 28
verapamilInjection: 2.5mg(hydrochloride)/mLin2mLampoule.Tablet:40mg;80mg(hydrochloride).
ComplementaryList
amiodaroneInjection:50mg/mLin3mLampoule(hydrochloride).Tablet:100mg;200mg;400mg(hydrochloride).
12.3 Antihypertensive medicines
amlodipine Tablet: 5 mg(asmaleate,mesylateorbesylate).
bisoprolol*
Tablet:1.25 mg;5mg.*includesatenolol,metoprololandcarvedilolasalternatives.Atenololshouldnotbeusedasafirstlineagentinuncomplicatedhypertensioninpatients>60years
enalapril Tablet: 2.5mg;5mg(ashydrogenmaleate).
hydralazine*
Powderforinjection: 20mg(hydrochloride)inampoule.Tablet:25mg;50mg(hydrochloride).*Hydralazineislistedforuseonlyintheacutemanagementofseverepregnancyinducedhypertension.Itsuseinthetreatmentofessentialhypertensionisnotrecommendedinviewoftheevidenceofgreaterefficacyandsafetyofothermedicines.
hydrochlorothiazideOralliquid:50mg/5 mL.Solidoraldosageform:12.5mg;25mg.
methyldopa*
Tablet:250mg.*Methyldopaislistedforuseonlyinthemanagementofpregnancyinducedhypertension.Itsuseinthetreatmentofessentialhypertensionisnotrecommendedinviewoftheevidenceofgreaterefficacyandsafetyofothermedicines.
ComplementaryListsodiumnitroprusside Powderforinfusion: 50mginampoule.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 29
12.4 Medicines used in heart failure
bisoprolol*Tablet:1.25 mg;5mg.*includesmetoprololandcarvedilolasalternatives.
digoxin
Injection: 250micrograms/ mLin2mLampoule.Oralliquid:50micrograms/mL.Tablet:62.5micrograms;250micrograms.
enalapril Tablet: 2.5mg;5mg(ashydrogenmaleate).
furosemide Injection: 10mg/ mL in2 mLampoule.Oralliquid:20mg/5mL[c].Tablet:40mg.
hydrochlorothiazide Oralliquid:50mg/5 mL.Solidoraldosageform:25mg.
spironolactone Tablet: 25mg.ComplementaryListdopamine Injection:40mg/mL(hydrochloride)in5mLvial.
12.5 Antithrombotic medicines
12.5.1 Anti-platelet medicines
acetylsalicylicacid Tablet: 100mg.clopidogrel Tablet:75mg;300mg12.5.2 Thrombolytic medicines
ComplementaryListstreptokinase Powderforinjection: 1.5millionIUinvial.
12.6 Lipid-lowering agents
simvastatin*Tablet: 5mg;10mg;20mg;40mg.*Foruseinhighriskpatients.
13. DERMATOLOGICAL MEDICINES (topical)
13.1 Antifungal medicines
miconazole Creamorointment:2%(nitrate).seleniumsulfide Detergentbasedsuspension:2%.sodiumthiosulfate Solution: 15%.
terbinafine Cream: 1% orOintment:1%terbinafinehydrochloride.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 30
13.2 Anti-infective medicines
mupirocinCream(asmupirocincalcium):2%.Ointment:2%.
potassiumpermanganate Aqueoussolution: 1:10000.
silversulfadiazinea Cream:1%.a >2 months.
13.3 Anti-inflammatory and antipruritic medicines
betamethasonea Creamorointment:0.1%(asvalerate).a Hydrocortisone preferred in neonates.
calamine Lotion.hydrocortisone Creamorointment:1%(acetate).13.4 Medicines affecting skin differentiation and proliferation
benzoylperoxide Creamorlotion: 5%.coaltar Solution: 5%.fluorouracil Ointment: 5%.podophyllumresin Solution: 10%to25%.salicylicacid Solution: 5%.urea Creamorointment: 5%;10%.13.5 Scabicides and pediculicides
benzylbenzoatea Lotion: 25%.a >2 years.
permethrinCream: 5%.
Lotion:1%.14. DIAGNOSTIC AGENTS
14.1 Ophthalmic medicines
fluorescein Eyedrops: 1%(sodiumsalt).tropicamide Eyedrops: 0.5%.14.2 Radiocontrast media
amidotrizoate Injection: 140mgto420mgiodine(assodium ormegluminesalt)/mLin20mLampoule.
bariumsulfate Aqueoussuspension.
iohexol Injection: 140mgto350mgiodine/mLin5 mL;10mL;20mLampoules.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 31
ComplementaryListbariumsulfate[c] Aqueoussuspension.meglumineiotroxate Solution:5gto8giodinein100mLto250mL.
15. DISINFECTANTS AND ANTISEPTICS
15.1 Antisepticschlorhexidine Solution:5%(digluconate).ethanol Solution: 70%(denatured).povidoneiodine Solution: 10% (equivalentto1%availableiodine).15.2 Disinfectants
alcoholbasedhandrub
Solutioncontainingethanol80%volume/volumeSolutioncontainingisopropylalcohol75%volume/volume
chlorinebasecompound Powder: (0.1%availablechlorine)forsolution.chloroxylenol Solution: 4.8%.glutaral Solution: 2%.
16. DIURETICS
amiloride Tablet: 5mg(hydrochloride).
furosemide Injection: 10mg/ mL in2 mLampoule.Oralliquid:20mg/5mL[c].Tablet:10mg[c];20mg[c];40mg.
hydrochlorothiazide Solidoraldosageform:25mg.mannitol Injectablesolution: 10%;20%.spironolactone Tablet: 25mg.
ComplementaryList[c]hydrochlorothiazide Tablet(scored):25mg.mannitol Injectablesolution:10%;20%.
spironolactone Oralliquid: 5mg/5 mL;10mg/5mL;25mg/5 mL.Tablet:25mg.
17. GASTROINTESTINAL MEDICINES
ComplementaryList[c]
pancreaticenzymes Ageappropriateformulationsanddosesincludinglipase,proteaseandamylase.
17.1 Antiulcer medicines
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 32
omeprazole Powderforinjection:40mginvialPowderfororalliquid:20mg;40mgsachets.Solidoraldosageform:10mg;20mg;40mg.
ranitidine
Injection: 25 mg/ mL (ashydrochloride)in2 mLampoule.Oralliquid:75mg/5mL(ashydrochloride).Tablet:150mg(ashydrochloride).
17.2 Antiemetic medicines
dexamethasone
Injection: 4mg/ mL in1 mL ampoule(asdisodiumphosphatesalt).Oralliquid:0.5mg/5mL;2mg/5mL.Solidoraldosageform:0.5mg;0.75mg;1.5mg;4mg.
metoclopramidea
Injection: 5mg(hydrochloride)/mLin2mLampoule.Oralliquid:5mg/5mL[c].Tablet:10mg(hydrochloride).a Not in neonates.
ondansetrona
Injection:2mgbase/ mL in2mLampoule(ashydrochloride).Oralliquid:4mgbase/5mL.Solidoraldosageform:Eq4mgbase;Eq8mgbase;Eq24mgbase.a >1 month.
17.3 Anti-inflammatory medicines
sulfasalazineRetentionenema.Suppository:500mg.Tablet:500mg.
ComplementaryList
hydrocortisoneRetentionenema.Suppository:25mg(acetate).(theonlyappliestohydrocortisoneretentionenema).
17.4 Laxatives
senna Tablet: 7.5mg(sennosides)(ortraditionaldosageforms).
17.5 Medicines used in diarrhoea
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 33
17.5.1 Oral rehydration
oralrehydrationsalts
Powderfordilution in200 mL;500mL;1L.glucose: 75mEqsodium: 75mEqormmol/Lchloride: 65mEqormmol/Lpotassium: 20mEqormmol/Lcitrate: 10mmol/Losmolarity: 245mOsm/Lglucose: 13.5g/Lsodiumchloride: 2.6g/Lpotassiumchloride: 1.5g/Ltrisodiumcitratedihydrate*: 2.9g/L*trisodiumcitratedihydratemaybereplacedbysodiumhydrogencarbonate(sodiumbicarbonate)2.5g/L.However,asthestabilityofthislatterformulationisverypoorundertropicalconditions,itisrecommendedonlywhenmanufacturedforimmediateuse.
17.5.2 Medicines for diarrhoea
zincsulfate*Solidoraldosageform: 20mg.*Inacutediarrhoeazincsulfateshouldbeusedasanadjuncttooralrehydrationsalts.
18. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
18.1 Adrenal hormones and synthetic substitutes
fludrocortisone Tablet:100micrograms(acetate).hydrocortisone Tablet:5mg;10mg;20mg.18.2 Androgens
ComplementaryListtestosterone Injection: 200mg(enanthate)in1mLampoule.
18.3 Contraceptives
18.3.1 Oral hormonal contraceptives
ethinylestradiol+levonorgestrel Tablet: 30micrograms+150micrograms.ethinylestradiol+norethisterone Tablet: 35micrograms+1mg.
levonorgestrel Tablet: 30micrograms;750micrograms(packoftwo);1.5mg.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 34
18.3.2 Injectable hormonal contraceptives
estradiolcypionate+medroxyprogesteroneacetate Injection:5mg+25mg.medroxyprogesteroneacetate Depotinjection: 150mg/ mL in1mLvial.norethisteroneenantate Oilysolution: 200mg/ mL in1mLampoule.18.3.3 Intrauterine devices
coppercontainingdevice
levonorgestrelreleasingintrauterinesystem Intrauterinesystemwithreservoircontaining52mgoflevonorestrel
18.3.4 Barrier methods
condoms diaphragms 18.3.5 Implantable contraceptives
etonogestrelreleasingimplant Singlerodetonogestrelreleasingimplant,containing68mgofetonogestrel.
levonorgestrelreleasingimplant Tworodlevonorgestrelreleasingimplant,eachrodcontaining75mgoflevonorgestrel(150mgtotal). 18.3.6 Intravaginal contraceptives
progesteronevaginalring*Progesteronereleasingvaginalringcontaining2.074gofmicronizedprogesterone.*Foruseinwomenactivelybreastfeedingatleast4timesperday
18.4 Estrogens
18.5 Insulins and other medicines used for diabetes
gliclazide*
Solid oraldosage form: (controlledrelease tablets)30mg;60mg;80mg.*glibenclamidenotsuitableabove60years.
glucagon Injection:1 mg/ mL.
insulininjection(soluble) Injection: 40IU/ mL in10 mLvial;100IU/mL in10mLvial.
intermediateactinginsulinInjection: 40IU/ mL in10 mLvial;100IU/mL in10mLvial(ascompoundinsulinzincsuspensionorisophaneinsulin).
metformin Tablet: 500mg(hydrochloride).ComplementaryList[c]metformin Tablet:500mg(hydrochloride).
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 35
18.6 Ovulation inducersComplementaryListclomifene Tablet:50mg(citrate).
18.7 Progestogens
medroxyprogesteroneacetate Tablet: 5mg.18.8 Thyroid hormones and antithyroid medicines
levothyroxine Tablet: 25micrograms [c];50micrograms;100micrograms(sodiumsalt).
potassiumiodide Tablet: 60mg.propylthiouracil Tablet: 50mg.
ComplementaryList[c]Lugolssolution Oralliquid:about130mgtotaliodine/mL.potassiumiodide Tablet:60mg.propylthiouracil Tablet:50mg.
19. IMMUNOLOGICALS
19.1 Diagnostic agents
AlltuberculinsshouldcomplywiththeWHOrequirementsfortuberculins.tuberculin,purifiedproteinderivative(PPD) Injection.19.2 Sera and immunoglobulins
AllplasmafractionsshouldcomplywiththeWHOrequirements.
Antivenomimmunoglobulin*Injection.
*Exacttypetobedefinedlocally.diphtheriaantitoxin Injection: 10000IU;20000IUinvial.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 36
19.3 Vaccines
WHO immunizationpolicy recommendations arepublished invaccinepositionpaperson thebasisofrecommendationsmadebytheStrategicAdvisoryGroupofExpertsonImmunization(SAGE).WHOvaccinepositionpapersareupdatedthreetofourtimesperyear.Thelistbelowdetailsthevaccinesforwhich there is a recommendation from SAGE and a correspondingWHO positionpaper as at 27February 2015. Themost recentversionsof theWHOpositionpapers, reflecting the current evidencerelatedtoaspecificvaccineandtherelatedrecommendations,canbeaccessedatanytimeontheWHOwebsiteat:http://www.who.int/immunization/documents/positionpapers/en/index.html.Vaccine recommendationsmay be universal or conditional (e.g., in certain regions, in some highriskpopulationsoraspartofimmunizationprogrammeswithcertaincharacteristics).Detailsareavailableinthe relevant position papers, and in the Summary Tables of WHO Routine ImmunizationRecommendationsavailableontheWHOwebsiteat:http://www.who.int/immunization/policy/immunization_tables/en/index.html.SelectionofvaccinesfromtheModelListwillneedtobedeterminedbyeachcountryafterconsiderationofinternationalrecommendations,epidemiologyandnationalpriorities.AllvaccinesshouldcomplywiththeWHOrequirementsforbiologicalsubstances.WHOnotedtheneedforvaccinesusedinchildrentobepolyvalent.Recommendationsforall BCGvaccinediphtheriavaccineHaemophilusinfluenzaetypebvaccinehepatitisBvaccineHPVvaccinemeaslesvaccinepertussisvaccinepneumococcalvaccinepoliomyelitisvaccinerotavirusvaccinerubellavaccinetetanusvaccineRecommendationsforcertainregionsJapaneseencephalitisvaccineyellowfevervaccinetickborneencephalitisvaccine
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 37
RecommendationsforsomehighriskpopulationscholeravaccinehepatitisAvaccinemeningococcalmeningitisvaccinerabiesvaccinetyphoidvaccineRecommendationsforimmunizationprogrammeswithcertaincharacteristicsinfluenzavaccine(seasonal)mumpsvaccinevaricellavaccine20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS
atracurium Injection: 10mg/ mL (besylate).
neostigmineInjection: 500microgramsin1mLampoule;2.5mg(metilsulfate)in1mLampoule.Tablet:15mg(bromide).
suxamethoniumInjection: 50mg(chloride)/ mLin2mLampoule.Powderforinjection(chloride),invial.
vecuronium[c] Powderforinjection:10mg(bromide)invial.ComplementaryList
pyridostigmineInjection: 1mgin1 mL ampoule.Tablet:60mg(bromide).
vecuronium Powderforinjection:10mg(bromide)invial.21. OPHTHALMOLOGICAL PREPARATIONS
21.1 Anti-infective agents
aciclovir Ointment: 3%W/W.azithromycin Solution(eyedrops):1.5%.gentamicin Solution(eyedrops):0.3%(sulfate).ofloxacin Solution(eyedrops): 0.3%.tetracycline Eyeointment: 1%(hydrochloride).21.2 Anti-inflammatory agents
prednisolone Solution(eyedrops): 0.5%(sodiumphosphate).
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 38
21.3 Local anaesthetics
tetracainea Solution(eyedrops): 0.5%(hydrochloride).a Not in preterm neonates.
21.4 Miotics and antiglaucoma medicines
acetazolamide Tablet: 250mg.latanoprost Solution(eyedrops): latanoprost50micrograms/mL
pilocarpine Solution(eyedrops): 2%;4%(hydrochloride ornitrate).
timolol Solution(eyedrops): 0.25%;0.5%(ashydrogenmaleate).21.5 Mydriatics
atropine*a
Solution(eyedrops): 0.1%;0.5%;1%(sulfate).*[c]Orhomatropine(hydrobromide)orcyclopentolate(hydrochloride).a >3 months.
ComplementaryListepinephrine(adrenaline) Solution(eyedrops):2%(ashydrochloride).
21.6 Anti-vascular endothelial growth factor (VEGF) preparationsComplementaryListbevacizumab Injection:25mg/mL.
22. OXYTOCICS AND ANTIOXYTOCICS
22.1 Oxytocics
ergometrine Injection: 200micrograms(hydrogenmaleate)in1mLampoule.
misoprostol
Tablet: 200micrograms. Managementofincompleteabortionandmiscarriage;
Preventionandtreatmentofpostpartumhaemorrhagewhereoxytocinisnotavailableorcannotbesafelyused
Vaginaltablet:25micrograms.**Onlyforuseforinductionoflabourwhereappropriatefacilitiesareavailable.
oxytocin Injection: 10IUin1 mL.ComplementaryList
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 39
mifepristone*misoprostol*Wherepermittedundernationallawandwhereculturallyacceptable.
Tablet200mgtablet200micrograms.*Requiresclosemedicalsupervision.
22.2 Antioxytocics (tocolytics)
nifedipine Immediatereleasecapsule: 10mg.23. PERITONEAL DIALYSIS SOLUTION
ComplementaryListintraperitonealdialysissolution(ofappropriatecomposition) Parenteralsolution.
24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS
24.1 Medicines used in psychotic disorders
chlorpromazine
Injection: 25mg(hydrochloride)/mLin2mLampoule.Oralliquid:25mg(hydrochloride)/5mL.Tablet:100mg(hydrochloride).
fluphenazine Injection: 25mg(decanoate orenantate)in1 mLampoule.
haloperidolInjection: 5mgin1 mL ampoule.Tablet:2mg;5mg.
risperidone Solidoraldosageform:0.25mgto6.0mg.ComplementaryList
chlorpromazine[c] Injection: 25mg(hydrochloride)/mLin2mLampoule.Oralliquid:25mg(hydrochloride)/5mL.Tablet:10mg;25mg;50mg;100mg(hydrochloride).
clozapine Solidoraldosageform:25to200mg.
haloperidol[c] Injection:5mgin1mLampoule.Oralliquid:2mg/mL.Solidoraldosageform:0.5mg;2mg;5mg.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 40
24.2 Medicines used in mood disorders24.2.1 Medicines used in depressive disordersamitriptyline Tablet: 25mg;75mg.(hydrochloride).fluoxetine Solidoraldosageform: 20mg(ashydrochloride).
ComplementaryList[c]
fluoxetinea Solidoraldosageform:20mg(ashydrochloride).a >8 years.
24.2.2 Medicines used in bipolar disorderscarbamazepine Tablet(scored): 100mg;200mg.lithiumcarbonate Solidoraldosageform:300mg.
valproicacid(sodiumvalproate) Tablet(entericcoated): 200mg;500mg(sodiumvalproate).
24.3 Medicines for anxiety disorders diazepam Tablet(scored): 2mg;5mg.24.4 Medicines used for obsessive compulsive disordersclomipramine Capsule: 10mg;25mg(hydrochloride).24.5 Medicines for disorders due to psychoactive substance use
nicotinereplacementtherapy(NRT)Chewinggum:2mg;4mg(aspolacrilex).Transdermalpatch:5mgto30mg/16hrs;7mgto21mg/24hrs.
ComplementaryList
methadone*
Concentratefororalliquid:5mg/mL;10mg/mL(hydrochloride).Oralliquid:5mg/5mL;10mg/5mL(hydrochloride).*Thesquareboxisaddedtoincludebuprenorphine.Themedicinesshouldonlybeusedwithinanestablishedsupportprogramme.
25. MEDICINES ACTING ON THE RESPIRATORY TRACT25.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease
beclometasoneInhalation(aerosol): 50 micrograms(dipropionate)perdose;100micrograms(dipropionate)perdose(asCFCfreeforms).
budesonide[c] Inhalation(aerosol): 100microgramsperdose;200microgramsperdose.
epinephrine(adrenaline)Injection: 1mg(ashydrochlorideorhydrogentartrate)in1mLampoule.
ipratropiumbromide Inhalation(aerosol):20micrograms/metereddose.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 41
salbutamol
Inhalation(aerosol): 100micrograms(assulfate)perdose.Injection: 50micrograms (as sulfate)/mL in 5mLampoule.Metereddoseinhaler(aerosol):100micrograms(assulfate)perdose.Respiratorsolutionforuse innebulizers:5mg (assulfate)/mL.
26. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACIDBASE DISTURBANCES26.1 Oraloralrehydrationsalts Seesection17.5.1.potassiumchloride Powderforsolution.26.2 Parenteral
glucose Injectablesolution: 5%(isotonic);10%(hypertonic);50%(hypertonic).
glucosewithsodiumchloride
Injectablesolution: 4%glucose,0.18%sodiumchloride(equivalenttoNa+30mmol/L,Cl30mmol/L).Injectablesolution:5%glucose,0.9%sodiumchloride(equivalenttoNa+150mmol/LandCl150mmol/L);5%glucose,0.45%sodiumchloride(equivalenttoNa+75mmol/LandCl75mmol/L)[c].
potassiumchloride
Solution: 11.2%in20 mL ampoule(equivalenttoK+1.5mmol/mL,Cl1.5mmol/mL).Solutionfordilution:7.5%(equivalenttoK1mmol/mLandCl1mmol/mL)[c];15%(equivalenttoK2mmol/mLandCl2mmol/mL)[c].
sodiumchloride Injectablesolution: 0.9%isotonic(equivalenttoNa+154mmol/L,Cl154mmol/L).
sodiumhydrogencarbonateInjectablesolution:1.4%isotonic(equivalenttoNa+167mmol/L,HCO3167mmol/L).Solution:8.4%in10mLampoule(equivalenttoNa+1000mmol/L,HCO31000mmol/L).
sodiumlactate,compoundsolution Injectablesolution.26.3 Miscellaneouswaterforinjection 2mL;5mL;10mLampoules.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 42
27. VITAMINS AND MINERALSascorbicacid Tablet: 50mg.calcium Tablet:500mg(elemental).
cholecalciferol*[c] Oralliquid: 400IU/ mL.Solidoraldosageform:400IU;1000IU.*Ergocalciferolcanbeusedasanalternative.
ergocalciferolOralliquid: 250micrograms/mL(10000IU/ mL).Solidoraldosageform:1.25mg(50000IU).
iodineCapsule: 200 mg.
Iodizedoil:1mL(480mgiodine);0.5mL(240mgiodine)inampoule(oralorinjectable);0.57mL(308mgiodine)indispenserbottle.
nicotinamide Tablet: 50mg.pyridoxine Tablet: 25mg(hydrochloride).
retinol
Capsule: 50000IU;100 000IU;200000IU(aspalmitate).Oraloilysolution:100000IU(aspalmitate)/mLinmultidosedispenser.Tablet(sugarcoated):10000IU(aspalmitate).Watermiscibleinjection:100000IU(aspalmitate)in2mLampoule.
riboflavin Tablet: 5mg.sodiumfluoride Inanyappropriatetopicalformulation.thiamine Tablet: 50mg(hydrochloride).
ComplementaryListcalciumgluconate Injection:100mg/mLin10mLampoule.
28. EAR, NOSE AND THROAT MEDICINES [c]
aceticacid Topical:2%,inalcohol. budesonide Nasalspray:100microgramsperdose. ciprofloxacin Topical:0.3%drops(ashydrochloride).
xylometazolinea Nasalspray: 0.05%.aNot in children less than 3 months.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 43
29. SPECIFIC MEDICINES FOR NEONATAL CARE 29.1 Medicines administered to the neonate [c]
caffeinecitrate Injection: 20 mg/ mL (equivalent to 10mg caffeinebase/mL).Oralliquid:20mg/mL(equivalentto10mgcaffeinebase/mL).
Chlorhexidine Solution or gel: 7.1% (digluconate) delivering 4%chlorhexidine(forumbilicalcordcare)[c].
ComplementaryListibuprofen Solutionforinjection:5mg/mL.
prostaglandinESolutionforinjection:ProstaglandinE1:0.5mg/mLinalcohol.ProstaglandinE2:1mg/mL.
surfactant Suspension for intratracheal instillation:25mg/mLor80mg/mL.
29.2 Medicines administered to the mother
dexamethasone Injection:4mg/ mL dexamethasonephosphate(asdisodiumsalt)
30. MEDICINES FOR DISEASES OF JOINTS
30.1 Medicines used to treat gout
allopurinol Tablet: 100mg.30.2 Disease-modifying agents used in rheumatoid disorders (DMARDs)
chloroquine Tablet: 100mg;150mg(asphosphateorsulfate).ComplementaryList azathioprine Tablet: 50mg.hydroxychloroquine[c] Solidoraldosageform: 200mg(assulfate).methotrexate Tablet:2.5mg(assodiumsalt).penicillamine Solidoraldosageform:250mg.sulfasalazine Tablet:500mg.
30.3 Juvenile joint diseases
acetylsalicylicacid*(acuteorchronicuse)
Suppository:50mgto150mg.Tablet:100mgto500mg.*Foruseforrheumaticfever,juvenilearthritis,Kawasakidisease.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 44
Table 1.1: Medicines with age or weight restrictions
atazanavir >25kgatropine >3monthsbenzylbenzoate >2yearsbetamethasonetopicalpreparations hydrocortisonepreferredinneonatescefazolin >1monthceftriaxone >41weekscorrectedgestationalagedarunavir >3yearsdiloxanide >25kgdoxycycline >8years(exceptforseriousinfectionse.g.cholera)efavirenz >3yearsor>10kgfluoxetine >8yearsibuprofen >3months(exceptIVformforpatentductusarteriosus)mefloquine >5kgor>3monthsmetoclopramide Notinneonatesnevirapine >6weeksondansetron >1monthsaquinavir >25kgsilversulfadiazine >2monthstetracaine Notinpretermneonatestrimethoprim >6monthsxylometazoline >3months
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 45
Table 1.2: Explanation of dosage forms
A. Principal dosage forms used in EML oral administration
Term
Definition
Solidoraldosageform
Referstotabletsorcapsulesorothersoliddosageformssuchasmeltsthatareimmediatereleasepreparations.Itimpliesthatthereisnodifferenceinclinicalefficacyorsafetybetweentheavailabledosageforms,andcountriesshouldthereforechoosetheform(s)tobelisteddependingonqualityandavailability.Thetermsolidoraldosageformisneverintendedtoallowanytypeofmodifiedreleasetablet.
Tablets
Refersto: uncoatedorcoated(filmcoatedorsugarcoated)tabletsthatare
intendedtobeswallowedwhole; unscoredandscored*; tabletsthatareintendedtobechewedbeforebeingswallowed; tabletsthatareintendedtobedispersedordissolvedinwateror
anothersuitableliquidbeforebeingswallowed; tabletsthatareintendedtobecrushedbeforebeingswallowed.Thetermtabletwithoutqualificationisneverintendedtoallowanytypeofmodifiedreleasetablet.
Tablets(qualified)
Referstoaspecifictypeoftablet:chewabletabletsthatareintendedtobechewedbeforebeingswallowed;dispersibletabletsthatareintendedtobedispersedinwateroranothersuitableliquidbeforebeingswallowed;solubletabletsthatareintendedtobedissolvedinwateroranothersuitableliquidbeforebeingswallowed;crushabletabletsthatareintendedtobecrushedbeforebeingswallowed;scoredtabletsbearingabreakmarkormarkswheresubdivisionisintendedinordertoprovidedosesoflessthanonetablet;sublingualtabletsthatareintendedtobeplacedbeneaththetongue.Thetermtabletisalwaysqualifiedwithanadditionalterm(inparentheses)inentrieswhereoneofthefollowingtypesoftabletisintended:gastroresistant(suchtabletsmaysometimesbedescribedasentericcoatedorasdelayedrelease),prolongedreleaseoranothermodifiedreleaseform.
* Scoredtabletsmaybedividedforeaseofswallowing,providedthatdoseisawholenumberoftablets.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 46
Term
Definition
Capsules
Referstohardorsoftcapsules.Thetermcapsulewithoutqualificationisneverintendedtoallowanytypeofmodifiedreleasecapsule.
Capsules(qualified)Thetermcapsulewithqualificationreferstogastroresistant(suchcapsulesmaysometimesbedescribedasentericcoatedorasdelayedrelease),prolongedreleaseoranothermodifiedreleaseform.
Granules
Preparationsthatareissuedtopatientasgranulestobeswallowedwithoutfurtherpreparation,tobechewed,ortobetakeninorwithwateroranothersuitableliquid.Thetermgranuleswithoutfurtherqualificationisneverintendedtoallowanytypeofmodifiedreleasegranules.
OralpowderPreparationsthatareissuedtopatientaspowder(usuallyassingledose)tobetakeninorwithwateroranothersuitableliquid.
Oralliquid
Liquidpreparationsintendedtobeswallowed i.e.oralsolutions,suspensions,emulsionsandoraldrops,includingthoseconstitutedfrompowdersorgranules,butnotthosepreparationsintendedfororomucosaladministratione.g.garglesandmouthwashes.Oralliquidspresentedaspowdersorgranulesmayofferbenefitsintheformofbetterstabilityandlowertransportcosts.Ifmorethanonetypeoforalliquidisavailableonthesamemarket(e.g.solution,suspension,granulesforreconstitution),theymaybeinterchangedandinsuchcasesshouldbebioequivalent.Itispreferablethatoralliquidsdonotcontainsugarandthatsolutionsforchildrendonotcontainalcohol.
B. Principal dosage forms used in EMLc parenteral administration
Term Definition
Injection Referstosolutions,suspensionsandemulsionsincludingthoseconstitutedfrompowdersorconcentratedsolutions.
Injection(qualified) Routeofadministrationisindicatedinparentheseswhererelevant.Injection(oily) Theterm`injectionisqualifiedby`(oily)inrelevantentries.Intravenousinfusion Referstosolutionsandemulsionsincludingthoseconstitutedfrom
powdersorconcentratedsolutions.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 47
C. Other dosage forms
Modeofadministration
Termtobeused
Totheeye Eyedrops,eyeointments.Topical Forliquids:lotions,paints.
Forsemisolids:cream,ointment.Rectal Suppositories,gelorsolution.Vaginal Pessariesorvaginaltablets.Inhalation Powderforinhalation,pressurizedinhalation,nebulizer.
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 48
Indexabacavir (ABC) 12 abacavir + lamivudine 13 acetazolamide 38 acetic acid 42 acetylcysteine 4 acetylsalicylic acid 2, 18, 29, 43 aciclovir 12, 37 albendazole 6 alcohol based hand rub 31 allopurinol 19, 43 all-trans retinoic acid (ATRA) 19 amidotrizoate 30 amikacin 11 amiloride 31 amiodarone 28 amitriptyline 2, 40 amlodipine 28 amodiaquine 16 amoxicillin 6 amoxicillin + clavulanic acid 6 amphotericin B 11, 15 ampicillin 7 anti-D immunoglobulin 26 antitetanus immunoglobulin 27 antivenom immunoglobulin 35 artemether 16 artemether + lumefantrine 16 artesunate 16 artesunate + amodiaquine 16 artesunate + mefloquine 16 ascorbic acid 42 asparaginase 19 atazanavir 13 atracurium 37 atropine 1, 4, 38 azathioprine 19, 43 azithromycin 8, 37 barium sulfate 30, 31 BCG vaccine 36 beclometasone 40 bedaquiline 11 bendamustine 19 benzathine benzylpenicillin 7 benznidazole 18 benzoyl peroxide 30 benzyl benzoate 30 benzylpenicillin 7 betamethasone 30 bevacizumab 38 bicalutamide 24 biperiden 25 bisoprolol 27, 28, 29 bleomycin 19 budesonide 40, 42 bupivacaine 1 caffeine citrate 43 calamine 30 calcium 42 calcium folinate 19 calcium gluconate 4, 42 capecitabine 19 capreomycin 11 carbamazepine 5, 40 carboplatin 20 cefalexin 7 cefazolin 7
cefixime 7 cefotaxime 7 ceftazidime 8 ceftriaxone 7 charcoal, activated 4 chlorambucil 20 chloramphenicol 8 chlorhexidine 31 chlorine base compound 31 chloroquine 16, 17, 43 chloroxylenol 31 chlorpromazine 39 chlorpromazine 39 cholecalciferol 42 cholera vaccine 37 ciclosporin 19 ciprofloxacin 8, 42 cisplatin 20 clarithromycin 8 clindamycin 9 clofazimine 9 clomifene 35 clomipramine 40 clopidogrel 29 clotrimazole 11 cloxacillin 7 clozapine 39 coagulation factor IX 27 coagulation factor VIII 27 coal tar 30 codeine 2 condoms 34 copper-containing device 34 cyclizine 2 cyclophosphamide 20 cycloserine 11 cytarabine 20 dacarbazine 20 daclatasvir 15 dactinomycin 20 dapsone 9 darunavir 13 dasabuvir 15 daunorubicin 21 deferoxamine 4, 26 delamanid 11 desmopressin 26 dexamethasone 2, 3, 24, 32, 43 dextran 70 27 diaphragms 34 diazepam 3, 5, 40 diethylcarbamazine 6 digoxin 27, 29 diloxanide 15 dimercaprol 4 diphtheria antitoxin 35 diphtheria vaccine 36 docetaxel 21 docusate sodium 3 dopamine 29 doxorubicin 21 doxycycline 8, 17 efavirenz (EFV or EFZ) 13 efavirenz + emtricitabine + tenofovir 13 eflornithine 18 emtricitabine + tenofovir 14
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 49
enalapril 28, 29 enoxaparin 25 entecavir 14 ephedrine 1 epinephrine (adrenaline) 3, 28, 38, 40 ergocalciferol 42 ergometrine 38 erythromycin 9 estradiol cypionate + medroxyprogesterone acetate 34 ethambutol 10 ethambutol + isoniazid 10 ethambutol + isoniazid + pyrazinamide + rifampicin 10 ethambutol + isoniazid + rifampicin 10 ethanol 31 ethinylestradiol + levonorgestrel 33 ethinylestradiol + norethisterone 33 ethionamide 11 ethosuximide 5 etonogestrel-releasing implant 34 etoposide 21 ferrous salt 25 ferrous salt + folic acid 25 filgrastim 22 fluconazole 11 flucytosine 11 fludarabine 21 fludrocortisone 33 fluorescein 30 fluorouracil 21, 30 fluoxetine 3, 40 fluphenazine 39 folic acid 25 fomepizole 4 fresh frozen plasma 26 furosemide 29, 31 gemcitabine 22 gentamicin 9, 37 gliclazide 34 glucagon 34 glucose 41 glucose with sodium chloride 41 glutaral 31 glyceryl trinitrate 27 griseofulvin 12 Haemophilus influenzae type b vaccine 36 haloperidol 3, 39 halothane 1 heparin sodium 25, 26 hepatitis A vaccine 37 hepatitis B vaccine 36 HPV vaccine 36 hydralazine 28 hydrochlorothiazide 28, 29, 31 hydrocortisone 3, 24, 30, 32, 33 hydroxocobalamin 25 hydroxycarbamide 22, 26 hydroxychloroquine 43 hyoscine butylbromide 3 hyoscine hydrobromide 3 ibuprofen 2, 18, 43 ifosfamide 22 imatinib 22 imipenem + cilastatin 8 influenza vaccine 37 insulin injection (soluble) 34 intermediate-acting insulin 34 intraperitoneal dialysis solution (of appropriate composition)
39
iodine 42 iohexol 30 ipratropium bromide 40 irinotecan 22 isoflurane 1 isoniazid 10 isoniazid + pyrazinamide + rifampicin 10 isoniazid + rifampicin 10 isosorbide dinitrate 27 ivermectin 6 Japanese encephalitis vaccine 36 kanamycin 11 ketamine 1 lactulose 3 lamivudine (3TC) 12 lamivudine + nevirapine + stavudine 14 lamivudine + nevirapine + zidovudine 14 lamivudine + zidovudine 14 latanoprost) 38 ledipasvir + sofosbuvir 15 leuprorelin 24 levamisole 6 levodopa + carbidopa 25 levofloxacin 11 levonorgestrel 33 levonorgestrel-releasing implant 34 levonorgestrel-releasing intrauterine system 34 levothyroxine 35 lidocaine 1, 28 lidocaine + epinephrine (adrenaline) 1 linezolid 11 lithium carbonate 40 loperamide 3 lopinavir + ritonavir (LPV/r) 13 loratadine 4 lorazepam 5 Lugol's solution 35 magnesium sulfate 5 mannitol 31 measles vaccine 36 mebendazole 6 medroxyprogesterone acetate 34, 35 mefloquine 17 meglumine iotroxate 31 melarsoprol 18 meningococcal meningitis vaccine 37 mercaptopurine 22 mesna 22 metformin 35 methadone 40 methotrexate 23, 43 methyldopa 28 methylprednisolone 24 methylthioninium chloride (methylene blue) 4 metoclopramide 32 metronidazole 9, 15 miconazole 29 midazolam 1, 3, 5 mifepristone 39 miltefosine 15 misoprostol 38, 39 morphine 1, 2 mumps vaccine 37 mupirocin 30 naloxone 4 neostigmine 37 nevirapine (NVP) 13 niclosamide 6
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 50
nicotinamide 42 nicotine replacement therapy (NRT) 40 nifedipine 39 nifurtimox 18 nitrofurantoin 9 nitrous oxide 1 norethisterone enantate 34 normal immunoglobulin 27 nystatin 12 ofloxacin 38 ombitasvir + paritaprevir + ritonavir 15 omeprazole 32 ondansetron 3, 32 oral rehydration salts 33, 41 oseltamivir 14 oxaliplatin 23 oxamniquine 6 oxygen 1 oxytocin 39 packed red blood cells 26 paclitaxel 23 p-aminosalicylic acid 11 pancreatic enzymes 31 paracetamol 2, 18 paromomycin 15 pegylated interferon alfa 2a 15 penicillamine 4, 43 pentamidine 18 permethrin 30 pertussis vaccine 36 phenobarbital 5 phenoxymethylpenicillin 7 phenytoin 5 phytomenadione 26 pilocarpine 38 platelet concentrates 26 pneumococcal vaccine 36 podophyllum resin 30 poliomyelitis vaccine 36 potassium chloride 41 potassium ferric hexacyano-ferrate(II) -2H20 (Prussian blue) 4 potassium iodide 12, 35 potassium permanganate 30 povidone iodine 31 praziquantel 6 prednisolone 4, 25, 38 primaquine 17 procaine benzylpenicillin 7 procarbazine 23 progesterone vaginal ring 34 proguanil 17 propofol 1 propranolol 18 propylthiouracil 35 prostaglandin E 43 protamine sulfate 26 pyrantel 6 pyrazinamide 10 pyridostigmine 37 pyridoxine 42 pyrimethamine 17 quinine 17 rabies immunoglobulin 26 rabies vaccine 37 ranitidine 32 retinol 42 ribavirin 14, 15 riboflavin 42
rifabutin 10 rifampicin 10 rifapentine 10 risperidone 39 ritonavir 13 rituximab 23 rotavirus vaccine 36 rubella vaccine 36 salbutamol 41 salicylic acid 30 saquinavir (SQV) 13 selenium sulfide 29 senna 3, 32 silver sulfadiazine 30 simeprevir 15 simvastatin 29 sodium calcium edetate 4 sodium chloride 41 sodium fluoride 42 sodium hydrogen carbonate 41 sodium lactate 41 sodium nitrite 4 sodium nitroprusside 28 sodium stibogluconate or meglumine antimoniate 16 sodium thiosulfate 4, 29 sofosbuvir 14 spectinomycin 9 spironolactone 29, 31 stavudine (d4T) 12 streptokinase 29 streptomycin 11 succimer 4 sulfadiazine 17 sulfadoxine + pyrimethamine 17 sulfamethoxazole + trimethoprim 9, 17 sulfasalazine 32, 43 suramin sodium 18 surfactant 43 suxamethonium 37 tamoxifen 25 tenofovir disoproxil fumarate 12, 14 terbinafine 29 testosterone 33 tetanus vaccine 36 tetracaine 38 tetracycline 38 thiamine 42 thioguanine 23 tick-borne encephalitis vaccine 37 timolol 38 tranexamic acid 26 trastuzumab 23 triclabendazole 6 trimethoprim 9 tropicamide 30 tuberculin, purified protein derivative (PPD) 35 typhoid vaccine 37 urea 30 valganciclovir 14 valproic acid (sodium valproate) 5, 6, 40 vancomycin 9 varicella vaccine 37 vecuronium 37 verapamil 27, 28 vinblastine 23 vincristine 24 vinorelbine 24 warfarin 26
EssentialMedicines 19theditionWHOModelList
19th WHO Model List of Essential Medicines (April 2015) page 51
water for injection 41 whole blood 26 xylometazoline 42
yellow fever vaccine 36 zidovudine (ZDV or AZT) 13 zinc sulfate 33
Top Related